Mapping the tumor‐derived mutations to the available crystal structures of the PBRM1 BDs 2, 4, and 5 (Filippakopoulos et al., 2010) provides further insight into the mechanism of how these mutations described in Table 1 may affect PBRM1 function. Here, PBRM1 is linked to neoplasm.